Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences
NCT ID: NCT05407129
Last Updated: 2025-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
656 participants
INTERVENTIONAL
2023-04-13
2028-10-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SAFER: A Brief Intervention Involving Family Members in Suicide Safety Planning
NCT03034863
Improving Hospital-to-Home Care Transitions for High-risk Younger Adult Patients
NCT02532296
Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)
NCT00692302
Family Partner Navigation for Children
NCT03569449
Using mHealth to Improve Emotional Recovery After Pediatric Injury
NCT04579198
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis 1A: The I-SHARE arm will detect higher rates of errors (via I-SHARE tool + VIR) than usual care (via VIR alone).
Hypothesis 1B: In the I-SHARE arm, rates of errors detected by the I-SHARE tool will exceed rates detected through VIR.
Hypothesis 1C: The I-SHARE arm will have higher safety experience, safety climate, and patient activation scores than usual care.
Hypothesis 2A: Among Spanish-speaking and less educated patients/families, the I-SHARE arm will detect higher rates of errors (via I-SHARE tool + VIR) than usual care (via VIR alone).
Hypothesis 2B: In the I-SHARE arm, Spanish-speaking and less educated patients/families will report equal rates of errors as English-speaking and more educated patients/families (via I-SHARE tool).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
This arm is the usual care arm of parents and providers who are randomized to proceed with usual care and are not given the family safety reporting intervention.
No interventions assigned to this group
Experimental: Intervention arm
This arm is the intervention arm of parents and providers who are randomized to the family safety reporting intervention on the study units.
Family safety reporting intervention
Family safety reporting intervention for patients/families
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family safety reporting intervention
Family safety reporting intervention for patients/families
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants speaking all languages are eligible
Exclusion Criteria
* In state custody
* Admitted for greater than 24 hours
* Same day discharge
* Covid positive
* Previously enrolled in I-SHARE
* Airborne illness precautions
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Pediatric Research in Inpatient Settings (PRIS)
UNKNOWN
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alisa Khan
Pediatric Hospitalist/Assistant Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alisa Khan, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital/Harvard Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Children's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-P00042333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.